The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.
Participants will be randomized into treatment vs. control group. Both groups will receive
regular inpatient medical treatment. Participants in the experimental arm will receive laser
treatments once daily for 4 days. Treatments will be delivered to the patients in a prone
position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard
nursing protocols would be used to identify participant's pulmonary status throughout
treatment.
Device: MLS Laser
Treatments will be delivered to the participants days 1-4, in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz.
Other: Regular Inpatient Medical Care
Regular inpatient medical care
Inclusion Criteria:
- COVID-19 positive
- Pulmonary compromise requiring oxygen support of approximately 2-6 liters
- Able to self prone, or support in self-sitting position
Exclusion Criteria:
- Ventilator management
- Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
- Pregnant women
Lowell General Hospital
Lowell, Massachusetts, United States
Scott Sigman, MD, Principal Investigator
Lowell General Hospital